Product Images Atelvia
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Atelvia NDC 0430-0979 by Allergan, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The chemical structure for Risedronate is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Each Atelvia tablet for oral administration contains the equivalent of 35 mg of anhydrous risedronate sodium in the form of the hemi-pentahydrate with small amounts of monohydrate. The empirical formula for risedronate sodium hemi-pentahydrate is C7H10NO7P2Na •2.5 H2O. The chemical name of risedronate sodium is [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] monosodium salt. - atelvia 01
![The chemical structure for Risedronate is a pyridinyl bisphosphonate that inhibits osteoclast-mediated bone resorption and modulates bone metabolism. Each Atelvia tablet for oral administration contains the equivalent of 35 mg of anhydrous risedronate sodium in the form of the hemi-pentahydrate with small amounts of monohydrate. The empirical formula for risedronate sodium hemi-pentahydrate is C7H10NO7P2Na •2.5 H2O. The chemical name of risedronate sodium is [1-hydroxy-2-(3-pyridinyl)ethylidene]bis[phosphonic acid] monosodium salt. - atelvia 01](https://ndclist.com/assets/spl/images/c8b9ab88-1a26-46c3-80ec-4eaa45202021/atelvia-01.jpg "atelvia-01.jpg")
Figure 1 - atelvia 02
The text appears to be a caption for Figure 1. The figure likely shows the cumulative incidence of nonvertebral osteoporosis-related fractures over a 3-year period, comparing the placebo group to those taking either ACTONEL 5mg or a combination of VERT MN and VERT NA. The notation "[]" may indicate some additional information, but without further context, its meaning is not clear.*
PRINCIPAL DISPLAY PANELNDC 0430-0979-03Atelvia 35 mg(risedronate sodium) delayed-release tabletsOnce-a-Week4 tabletsRx Only - atelvia 03
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.